Emv Capital (EMVC) RNS Announcements

Add to Alert list
Date Time Source Announcement
02 Feb 2026 07:00 AM
RNS
Trading and Portfolio Update
08 Jan 2026 07:00 AM
RNS
PDMR Dealing
23 Dec 2025 07:00 AM
RNS
Sofant Technologies: Fundraising
19 Dec 2025 07:00 AM
RNS
Director/PDMR Dealing
10 Dec 2025 07:00 AM
RNS
Wanda Health: Fundraising and Business Update
08 Dec 2025 07:00 AM
RNS
Share Issue, PDMR Dealings & Total Voting Rights
04 Dec 2025 07:00 AM
RNS
TR-1
24 Nov 2025 07:00 AM
RNS
Expansion of Senior Finance Leadership Team
20 Nov 2025 07:00 AM
RNS
Portfolio Update
30 Sep 2025 07:00 AM
RNS
Interim Results and Investor Presentation
22 Sep 2025 07:00 AM
RNS
Asset Purchase Agreement with Destiny Pharma
18 Sep 2025 07:00 AM
RNS
Notice of Interim Results
30 Jun 2025 12:22 PM
RNS
Result of AGM
30 Jun 2025 07:00 AM
RNS
Office move and Related Party Transaction
27 Jun 2025 07:00 AM
RNS
Q-Bot Limited Fundraising
10 Jun 2025 01:28 PM
RNS
TR-1
06 Jun 2025 03:12 PM
RNS
Notice of AGM and Annual Report & Accounts
04 Jun 2025 02:34 PM
RNS
Director/PDMR Shareholding
04 Jun 2025 07:00 AM
RNS
Preliminary results for the year ended 31 Dec 2024
14 May 2025 04:02 PM
RNS
PDS: Q1 Results and Clinical and Corporate Update
09 May 2025 10:30 AM
RNS
TR-1
27 Mar 2025 04:46 PM
RNS
PDS: Q4 Results and Clinical Programs Update
07 Mar 2025 04:26 PM
RNS
PDS: VERSATILE-003 Phase 3 Clinical Trial
27 Feb 2025 04:30 PM
RNS
PDS: up to $22mn Registered Direct Offering
05 Feb 2025 03:24 PM
RNS
PDS Biotech reaffirms guidance for clinical trial
03 Feb 2025 07:00 AM
RNS
ProAxsis: Status Update and Proposed Fundraise
06 Jan 2025 04:42 PM
RNS
TR-1
31 Dec 2024 07:05 AM
RNS
Grant of Share Options
31 Dec 2024 07:00 AM
RNS
Q-Bot Fundraising
12 Dec 2024 04:49 PM
RNS
TR-1
09 Dec 2024 07:00 AM
RNS
Wanda Health Fundraising
05 Dec 2024 07:00 AM
RNS
Close of Fundraising and Result of Retail Offer
03 Dec 2024 01:24 PM
RNS
Result of Subscription
03 Dec 2024 07:05 AM
RNS
WRAP Retail Offer
03 Dec 2024 07:00 AM
RNS
Proposed Subscription and Retail Offer; Update
14 Nov 2024 03:59 PM
RNS
Replacement RNS: PDS: Update, 3rd Quarter Results
14 Nov 2024 03:23 PM
RNS
PDS: Clinical Programs Update, 3rd Quarter Results
08 Oct 2024 07:00 AM
RNS
Director/PDMR Shareholding
03 Oct 2024 07:00 AM
RNS
Director/PDMR Shareholding
02 Oct 2024 04:38 PM
RNS
PDS: 36-Month Overall Survival Rate announcement
30 Sep 2024 07:00 AM
RNS
Interim Results
26 Sep 2024 07:00 AM
RNS
Name change and AIM Rule 26 website
16 Sep 2024 02:31 PM
RNS
PDS: Updated Results, VERSATILE-002 Phase 2 Trial
13 Aug 2024 03:57 PM
RNS
PDS Biotech: Business Update and Q2 2024 Results
02 Aug 2024 12:21 PM
RNS
Replacement RNS: PDS Biotech Aligns with FDA
02 Aug 2024 07:00 AM
RNS
PDS Biotech Aligns with FDA on Phase 3 Trial
30 Jul 2024 07:00 AM
RNS
Q-Bot Fundraising
10 Jul 2024 10:48 AM
RNS
Result of AGM
18 Jun 2024 07:00 AM
RNS
Notice of AGM
14 Jun 2024 02:10 PM
RNS
TR-1

EMV Capital is a London venture capital company that invests in early-stage, IP-rich, technology and life sciences companies in the UK and internationally.

It is listed on AIM under the ticker EMVC.

EMVC share price launched at 1,620p in 2013.

UK 100

Latest directors dealings